Agilent Cell Analysis Webinar Series
A Next Generation Tool Bench for Virology Research
The next generation of vaccines and anti-viral therapies require a new generation of analysis tools.
Research advancing our understanding of host-pathogen and host-immune response to virus infection is critical and timely under the current global pandemic.
Discover Agilent’s new end-to-end solutions for virology disease research, drug discovery and vaccine development, enabling translational researchers and developers to address present and future challenges in global human health and infectious disease.
Register for our Virtual Roadshow, where we will be joined by Dr. Peter Mullen from the University of California, Los Angeles. Learn also from Agilent product experts who will showcase relevant product lines and assays, including Seahorse XF technology, xCELLigence RTCA, NovoCyte Flow Cytometry & BioTek Instruments, supported by published application examples from the field.